SEC Company Response from Propanc Biopharma, Inc. (PPCB) (CIK 0001517681) (PPCB) — Jun 20, 2019

Propanc Biopharma, Inc. (PPCB) (CIK 0001517681)
Date: June 20, 2019 · CIK: 0001517681 · Accession: 0001493152-19-009488

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-231682

Date

June 20, 2019

Author

PROPANC

Form

CORRESP

Company

Propanc Biopharma, Inc. (PPCB) (CIK 0001517681)

Letter

PROPANC BIOPHARMA, INC.

302, 6 Butler Street

Camberwell, VIC, 3124 Australia

June 20,

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

F Street N.E.

Washington, D.C. 20549

Attention: Sonia Bednarowski

Re: Propanc Biopharma, Inc.

Registration Statement on Form S-1 (the “Registration Statement”)

File No. 333-231682

Ladies and Gentlemen:

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Propanc Biopharma, Inc. hereby requests that the effective date of the above-referenced Registration Statement be accelerated so that it will become effective at 12:00 P.M. Eastern Daylight Time on Friday, June 21, 2019, or as soon as practicable thereafter.

We respectfully request that we be notified of such effectiveness by a telephone call to Sasha Ablovatskiy, Esq. of Foley Shechter Ablovatskiy LLP at (212) 335-0466, or in his absence Jonathan Shechter, Esq. of Foley Shechter Ablovatskiy LLP at (212) 335-0465.

Sincerely,
PROPANC
BIOPHARMA, INC.

Show Raw Text

CORRESP
1
filename1.htm

PROPANC
BIOPHARMA, INC.

302,
6 Butler Street

Camberwell,
VIC, 3124 Australia

    June 20,
    2019

VIA
EDGAR

United
States Securities and Exchange Commission

Division
of Corporation Finance

100
F Street N.E.

Washington,
D.C. 20549

Attention:
Sonia Bednarowski

    Re:
    Propanc
    Biopharma, Inc.

    Registration
    Statement on Form S-1 (the “Registration Statement”)

    File
    No. 333-231682

Ladies
and Gentlemen:

Pursuant
to Rule 461 promulgated under the Securities Act of 1933, as amended, Propanc Biopharma, Inc. hereby requests that the effective
date of the above-referenced Registration Statement be accelerated so that it will become effective at 12:00 P.M. Eastern Daylight
Time on Friday, June 21, 2019, or as soon as practicable thereafter.

We
respectfully request that we be notified of such effectiveness by a telephone call to Sasha Ablovatskiy, Esq. of Foley Shechter
Ablovatskiy LLP at (212) 335-0466, or in his absence Jonathan Shechter, Esq. of Foley Shechter Ablovatskiy LLP at (212) 335-0465.

    Sincerely,

    PROPANC
    BIOPHARMA, INC.

    By:
    /s/
James Nathanielsz

    Name:
    James
    Nathanielsz

    Title:
    Chief
    Executive Officer

    Cc:
    Jonathan
    Shechter, Esq. of Foley Shechter Ablovatskiy LLP

    Sasha
    Ablovatskiy, Esq. of Foley Shechter Ablovatskiy LLP

SecProbe.io